ArmorFlex® 110 Film Frequently Asked Questions
At ILC Dover, we are always "creating what’s next" by listening carefully to our customers. In response to customer input and emerging regulations, we've developed a robust new film to support our DoverPac® Containment Solutions line. This revolutionary product, ArmorFlex® 110, delivers permanent static dissipative properties while meeting FDA and 2002/72/EC requirements for food contact.
WHITE PAPERS & CASE STUDIES
Prevent Combustible Dust Explosions In Pharmaceutical Manufacturing
More than 100 people have been killed in manufacturing plants from explosions caused by combustible dust. This type of dust can be found in active pharmaceutical ingredients, during the production of oral solid dosage drugs. Initial blasts are enough to contend with, but their ability to stir up additional dust for a secondary explosion can potentially neutralize an entire facility.
Be In Control Of Product Quality – Do Not Just Rely, But Understand
Maik W. Jornitz, President, G-CON Manufacturing LLC
Past experiences have shown that too often product quality is based on sole reliance of vendor certifications, statements and promises. To diminish such reliance new technologies started to be implemented, like process analytical technologies (PAT), process controls, automation etc. often once again overexerted as the solution to all problems. Activities that supposedly result in higher product quality due to better process controls. Maik W. Jornitz, Chief Operating Officer, G-CON Manufacturing LLC
Creating The Next Generation Of Isolation
Containment technology has emerged as one of the major trends in the processing and manufacture of pharmaceuticals. Part of the reason for this is continuous quality improvement, which relies on new and improved containment technologies to enhance production. By Bosch Packaging Technology
The Key To API Containment And Control
When sampling and dosing active pharmaceutical ingredients (APIs) or high-potency APIs (HPAPIs), containment can be critical. Good laboratory practices (GLP) and the proper equipment designed and calibrated to facilitate GLP when transferring, mixing or blending APIs can reduce product waste, product contamination and minimize lost profit as well as create a healthier, contaminant free environment for lab operators. By Jason Frye
Drastically Reduced Isolator Decontamination Cycles
With the use of catalytic aeration, M + P is able to reduce the duration of the aeration phase in isolators by about 50 %. The aeration phase is the most time consuming cycle during H2O2 decontamination. By Felix Henning, Optima Packaging Group GmbH
Emerging Fourth Generation Pharmaceutical Containment Technologies
Barrier technology has become overwhelmingly accepted as the basis for new aseptic processing facilities in 2013. The traditional clean room facilities of the 20th century are being rapidly replaced with advanced barrier based technology filling facilities. This technological evolution is dramatically reducing the risk of product contamination and risk of infection to patients. By Sterling Kline, RA IPS